Log In
Print this Print this

Atrovent HFA

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionIpratropium bromide formulated with non-chlorofluorocarbon propellant hydrofluoroalkane (HFC)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat bronchospasm associated with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today